CACI Awarded Task Order to Support Defense Intelligence Agency (DIA) National Center for Medical Intelligence
20 12월 2023 - 6:15AM
Business Wire
CACI International Inc (NYSE: CACI) announced today that it won
a single-award, five-year task order to provide expertise to the
Defense Intelligence Agency (DIA) National Center for Medical
Intelligence (NCMI). This new contract with the Defense Medical
Intelligence and Global Health Security (DMIGHS) includes enhanced
activities assisting NCMI in effectively providing medical
intelligence support on foreign health threats and other medical
issues to protect U.S. interests worldwide. This work is part of
the Solutions for Intelligence Analysis 3 (SIA 3) indefinite
delivery, indefinite quantity (IDIQ) contract vehicle.
“CACI is proud to take on this new challenge with our
longstanding customer, DIA, to provide expert intelligence and
analysis support to assist intelligence gathering for the National
Center for Medical Intelligence,” said John Mengucci, CACI
President and Chief Executive Officer. “CACI’s experts are uniquely
qualified to help DIA achieve information advantage by
strengthening the agency’s ability to confidently and accurately
transform data into actionable insights and meet critical
intelligence analysis objectives.”
NCMI protects the nation by providing evaluation and all-source
analysis of worldwide health threats and issues, including foreign
medical capabilities, infectious disease, environmental health
risks, developments in biotechnology and biomedical subjects of
national and military importance, and support to force protection.
CACI performs intelligence analysis focused on medical protection,
identification, and analysis of foreign health threats to better
protect U.S. interests both domestically and internationally.
About CACI
At CACI International Inc (NYSE: CACI), our 23,000 talented and
dynamic employees are ever vigilant in delivering distinctive
expertise and differentiated technology to meet our customers’
greatest challenges in national security and government
modernization. We are a company of good character, relentless
innovation, and long-standing excellence. Our culture drives our
success and earns us recognition as a Fortune World's Most Admired
Company. CACI is a member of the Fortune 1000 Largest Companies,
the Russell 1000 Index, and the S&P MidCap 400 Index. For more
information, visit us at www.caci.com.
There are statements made herein which do not address historical
facts, and therefore could be interpreted to be forward-looking
statements as that term is defined in the Private Securities
Litigation Reform Act of 1995. Such statements are subject to
factors that could cause actual results to differ materially from
anticipated results. The factors that could cause actual results to
differ materially from those anticipated include, but are not
limited to, the risk factors set forth in CACI’s Annual Report on
Form 10-K for the fiscal year ended June 30, 2023, and other such
filings that CACI makes with the Securities and Exchange Commission
from time to time. Any forward-looking statements should not be
unduly relied upon and only speak as of the date hereof.
CACI-Category-Business Wire
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231219993373/en/
Corporate Communications and Media: Lorraine Corcoran
Executive Vice President, Corporate Communications (703) 434-4165,
lorraine.corcoran@caci.com
Investor Relations: George Price Senior Vice President,
Investor Relations (703) 841-7818, george.price@caci.com
CACI (NYSE:CACI)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
CACI (NYSE:CACI)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024